1. Home
  2. BDSX vs ATNM Comparison

BDSX vs ATNM Comparison

Compare BDSX & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • ATNM
  • Stock Information
  • Founded
  • BDSX 2005
  • ATNM 2000
  • Country
  • BDSX United States
  • ATNM United States
  • Employees
  • BDSX N/A
  • ATNM N/A
  • Industry
  • BDSX Precision Instruments
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • BDSX Health Care
  • ATNM Health Care
  • Exchange
  • BDSX Nasdaq
  • ATNM Nasdaq
  • Market Cap
  • BDSX 53.2M
  • ATNM 50.2M
  • IPO Year
  • BDSX 2020
  • ATNM N/A
  • Fundamental
  • Price
  • BDSX $6.21
  • ATNM $1.61
  • Analyst Decision
  • BDSX Strong Buy
  • ATNM Strong Buy
  • Analyst Count
  • BDSX 5
  • ATNM 2
  • Target Price
  • BDSX $35.00
  • ATNM $4.50
  • AVG Volume (30 Days)
  • BDSX 273.2K
  • ATNM 122.2K
  • Earning Date
  • BDSX 10-31-2025
  • ATNM 11-13-2025
  • Dividend Yield
  • BDSX N/A
  • ATNM N/A
  • EPS Growth
  • BDSX N/A
  • ATNM N/A
  • EPS
  • BDSX N/A
  • ATNM N/A
  • Revenue
  • BDSX $76,556,000.00
  • ATNM N/A
  • Revenue This Year
  • BDSX $18.80
  • ATNM N/A
  • Revenue Next Year
  • BDSX $27.76
  • ATNM N/A
  • P/E Ratio
  • BDSX N/A
  • ATNM N/A
  • Revenue Growth
  • BDSX 25.70
  • ATNM N/A
  • 52 Week Low
  • BDSX $3.44
  • ATNM $1.03
  • 52 Week High
  • BDSX $37.00
  • ATNM $2.41
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 51.49
  • ATNM 45.72
  • Support Level
  • BDSX $0.37
  • ATNM $1.60
  • Resistance Level
  • BDSX $8.40
  • ATNM $1.70
  • Average True Range (ATR)
  • BDSX 0.92
  • ATNM 0.07
  • MACD
  • BDSX -0.06
  • ATNM -0.01
  • Stochastic Oscillator
  • BDSX 55.98
  • ATNM 32.14

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: